Alvotech (NASDAQ:ALVO) is one of the penny stocks with explosive growth potential. On June 18, Alvotech closed its underwritten public offering of 26,066,667 ordinary shares at $3.75 per share, raising ~$98 million in gross proceeds. This figure includes the full exercise of the underwriters’ option to purchase additional shares. The offering is complemented by a concurrent private placement of 17,826,666 shares at the same price, which is expected to raise an additional $67 million and close by June 25.
Combined, these transactions will result in total gross proceeds of ~$165 million. Following the completion of the private placement, the company’s total issued share capital will increase to 390,431,480 ordinary shares. BofA Securities, Jefferies, and Evercore ISI served as the joint book-running managers for the public offering.
Alvotech (NASDAQ:ALVO) plans to use the net proceeds from these capital-raising activities to fund the ongoing development of its biosimilar portfolio. Other planned uses for the funds include working capital, general corporate purposes such as intellectual property protection, commercial and capital expenditures, research and development, and the potential repayment or refinancing of existing corporate debt.
Alvotech (NASDAQ:ALVO) is a biotechnology company that develops and manufactures biosimilar medicines. The firm’s focus is on the development of its product candidates, with its operations divided into the following geographical segments: Europe, North America, Asia, and Other.
While we acknowledge the risk and potential of ALVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ALVO and that has 10,000% upside potential, check out our report about the cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
